secoisolariciresinol has been researched along with Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutta, S; Khanna, A; Kharkar, PS; Sahu, NU | 1 |
| Briese, V; Gerber, B; Richter, DU; Theil, C | 1 |
| Anisimova, NY; Fetisova, LV; Kiselevskii, MV; Men'shov, VM; Nifant'ev, NE; Scherbakov, AM; Shcherbakov, AE; Trishin, AV; Tsvetkov, DE; Yashunskii, DV; Zhukova, OS | 1 |
| Abarzua, S; Briese, V; Piechulla, B; Richter, DU; Serikawa, T; Szewczyk, M | 1 |
4 other study(ies) available for secoisolariciresinol and Breast Cancer
| Article | Year |
|---|---|
Molecular docking prediction and in vitro studies elucidate anti-cancer activity of phytoestrogens.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Breast Neoplasms; Butylene Glycols; Caspase 3; Caspase 7; Cell Line, Tumor; Computer Simulation; Down-Regulation; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genistein; Humans; Isoflavones; Lignans; MCF-7 Cells; Molecular Docking Simulation; Phytoestrogens | 2017 |
The effects of different lignans and isoflavones, tested as aglycones and glycosides, on hormone receptor-positive and -negative breast carcinoma cells in vitro.
Topics: Breast Neoplasms; Butylene Glycols; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Genistein; Humans; Immunohistochemistry; Isoflavones; L-Lactate Dehydrogenase; Lignans; Phytoestrogens; Receptors, Estrogen; Receptors, Progesterone | 2011 |
In vitro effect of Knotolan, a new lignan from Abies sibirica, on the growth of hormone-dependent breast cancer cells.
Topics: Abies; Breast Neoplasms; Butylene Glycols; Cell Line, Tumor; Cell Proliferation; Estradiol; Female; Humans; Lignans; Neoplasms, Hormone-Dependent | 2010 |
Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20.
Topics: 4-Butyrolactone; Anticarcinogenic Agents; Breast Neoplasms; Butylene Glycols; Cell Line, Tumor; Cell Proliferation; Estradiol; Estrogens; Female; Furans; Humans; Lignans; Phytoestrogens; Selective Estrogen Receptor Modulators; Tamoxifen | 2012 |